July 6 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
News: KZA Us FDA Awards Rare Pediatric Disease Designation To Paxalisib
Add to My Watchlist
What is My Watchlist?